|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 229/50 | |
| A61P 25/24 | |||
| A61K 31/21 |
| (11) | Patento numeris | 2640687 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11793573.4 |
| Europos patento paraiškos padavimo data | 2011-11-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-06-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/060686 |
| Data | 2011-11-15 |
| (87) | Numeris | WO 2012/068041 |
| Data | 2012-05-24 |
| (30) | Numeris | Data | Šalis |
| 415113 P | 2010-11-18 | US |
| (72) |
DRESSMAN, Bruce Anthony, US
CHAPPELL, Mark Donald, US
FIVUSH, Adam Michael, US
MITCH, Charles Howard, US
ORNSTEIN, Paul Leslie, US
TROMICZAK, Eric George, US
VETMAN, Tatiana Natali, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS |
| 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS |